Articles
Aims and scope
BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.
Sections
Epidemiology, prevention and public health
Experimental therapeutics and drug development
Genetics, genomics and epigenetics
Infection, immunity and cancer vaccines
Medical and radiation oncology
Surgical oncology, cancer imaging, and interventinal therapeutics
Systems biology, post-genomic analysis and emerging technologies
BMC Series blog
-
Respectful maternity care – the way forward
15 February 2019
-
Highlights of the BMC Series: January 2019
14 February 2019
-
The obesity-paradox: impact of body composition on cancer survival
12 February 2019
Editor
- Linda Gummlich, BioMedical Central, UK
Consulting Editors
- Yanis Boumber, Fox Chase Cancer Center
- Ken Herrmann, Universitätsklinikum Essen
- Manami Inoue, National Cancer Center
- Alan Lefor, Jichi Medical University
- Christophe Nicot, Kansas University Medical Center
- Stephen Povoski, The Ohio State University
- Dirk Vordermark, Martin Luther University Halle-Wittenberg
Follow
2017 Journal Metrics
-
Citation Impact
3.288 - 2-year Impact Factor
3.679 - 5-year Impact Factor
1.066 - Source Normalized Impact per Paper (SNIP)
1.464 - SCImago Journal Rank (SJR)Usage
3,549,437 downloadsSocial Media Impact
2273 mentions